MRK vs ORCL: Which Is the Better Buy?
Side-by-side comparison of Merck & Co., Inc. and Oracle Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-23.
Merck & Co., Inc. · Healthcare
$147.17
-4.1% upside to fair value
Med Conviction
Grade C
VS
Oracle Corporation · Technology
$149.12
+45.0% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
ORCL has more upside to fair value
(+45.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MRK |
ORCL |
| Current Price |
$147.17 |
$149.12 |
| Fair Value Estimate |
$141.07 |
$216.22 |
| Upside to Fair Value |
-4.1%
|
+45.0%
|
| Market Cap |
$363.5B |
$429.5B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
29.6x
|
14.6x
|
| Price / Sales |
5.5x
|
6.0x
|
| Price / FCF |
22.6x
|
—
|
| Revenue Growth YoY |
+5.1%
|
+29.6%
|
| Gross Margin |
75.4%
|
63.9%
|
| Operating Margin |
16.7%
|
32.4%
|
| Return on Equity |
6.6%
|
42.6%
|
| Dividend Yield |
2.31% |
1.34% |
| FCF Yield |
4.42%
|
—
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Merck & Co., Inc. is a global healthcare leader with two core divisions, Pharmaceuticals and Animal Health, spanning oncology, vaccines, acute hospital care, immunology, neuroscience, virology, cardiovascular and diabetes, and it employs roughly 74,000 people under CEO Robert Davis. The business quality is medium: TTM gross margin of 75.4% and TTM operating margin of 16.7% reflect a genuinely hig…
Oracle is a global enterprise software and cloud infrastructure provider whose portfolio spans the Oracle Database, Java, Fusion Cloud SaaS applications (ERP, EPM, SCM, HCM), NetSuite, and Oracle Cloud Infrastructure, sold through a direct sales force to businesses, governments, and educational institutions worldwide. The business quality is high on fundamentals: trailing-twelve-month gross margi…
Accumulation Zones
| Metric |
MRK |
ORCL |
| Zone Low |
$105.80 |
$162.16 |
| Zone High |
$119.91 |
$183.79 |
| In Buy Zone? |
No
|
Yes
|